Reuters
New data fuel hopes for broad use of Novartis psoriasis drugReutersBASEL, Switzerland Novartis is increasingly confident about the potential of its new injectable drug Cosentyx, as fresh clinical data confirms its long-term benefits in treating psoriatic arthritis. Cosentyx was approved by the U.S. Food and Drug Administration in ...Novartis announces publication in The Lancet showing sustained efficacy with ...Nasdaqall 3 news articles »
Home /
mesothelioma /
mesothelioma law firm /
New data fuel hopes for broad use of Novartis psoriasis drug
Sunday, June 28, 2015
New data fuel hopes for broad use of Novartis psoriasis drug
By
Unknown
On
4:32 PM
Subscribe to:
Post Comments (Atom)